Features Partner Sites Information LinkXpress
My Account
Advertise with Us
RANDOX LABORATORIES

Aurora Kinase A Prevents p53 from Inducing Stem Cell Differentiation

By BiotechDaily International staff writers
Posted on 22 Aug 2012
Print article
An oncoprotein called aurora kinase A (Aurka) helps maintain embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) in the primitive pluripotent state by blocking the action of the tumor suppressor gene p53 that would otherwise induce the stem cells to differentiate.

To determine the mechanism that functions to maintain stem cell status, investigators at Mount Sinai School of Medicine (New York, NY, USA) conducted a short hairpin (sh) RNA screen of 104 ESC-associated phosphoregulators. They reported in the August 3, 2012, issue of the journal Cell Stem Cell that depletion of one such molecule (Aurka), resulted in compromised self-renewal and consequent differentiation.

By integrating global gene expression and computational analyses, they showed that loss of Aurka led to upregulated p53 activity that triggered ESC differentiation. Specifically, Aurka regulated pluripotency through phosphorylation-mediated inhibition of p53-directed ectodermal and mesodermal gene expression. Phosphorylation of p53 not only impaired p53-induced ESC differentiation but also p53-mediated suppression of iPSC reprogramming.

“These studies are exciting not only from a basic science point-of-view, but also because they suggest that stem cell research may impact the development of novel treatments for cancer. Conversely, cancer research may facilitate the realization of the biomedical potential of stem cells,” said senior author Dr. Ihor Lemischka, professor of developmental and regenerative biology at Mount Sinai School of Medicine.

Related Links:
Mount Sinai School of Medicine



Print article

Channels

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Business

view channel

Collaborative Agreement to Aid in Setting Guidelines for Evaluating Potential Ebola Therapy

Cooperation between an Israeli biopharmaceutical company and medical branches of the US government is designed to set ground rules for continued evaluation of an experimental therapy for Ebola virus disease. RedHill Biopharma Ltd. (Tel Aviv, Israel), a biopharmaceutical company primarily focused on development and c... Read more
Copyright © 2000-2017 Globetech Media. All rights reserved.